Credits Available: 3.25 AMA PRA Category 1 Credits

MS is the leading cause of non-traumatic disability in adults over the age of 50 and has become a focus of evolving research. In just the past two decades, a greater understanding of the pathogenesis of MS has led to a litany of new FDA approved therapies. In fact, there are now 18 DMTs representing nine therapeutic classes approved for use in the US with multiple late stage medications poised to join them. This curriculum
is designed to help participants improve their MS management skills by distilling the most relevant and valuable information for their patients.

Self Study

Live Group Discussions

  • Live Group Discussion 1: Module-Based Review

    This discussion will be based on the group’s collective responses to the self-assessments in the self-study modules. The focus will be topics where the most heterogeneity between group members and/or divergence from group leaders’ recommendations is seen.

  • Live Group Discussion 2: Group Task Review

    This discussion will center around responses to the group tasks, emphasizing your own questions, points of uncertainty, and disagreements. It will allow for open dialogue surrounding strategic decision making in order to help guide useful ways of thinking when faced with carrying clinical scenarios.

Group Challenge

  • Clinical Experience with New Agents

    This Group Task will involve discussion of real world experience with new agents and strategies for multiple sclerosis. You will have the opportunity to gauge your own strategies and pose questions surrounding obstacles in day-to-day practice.

  • Treatment Resistance and Side Effect Management

    Not all patients respond well to all therapies. This Group Task will allow you to present/view challenging clinical scenarios of patients who are resistant to treatment efforts or experiencing difficult side effects.

Curriculum is Currently Closed

Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.

View Other Offerings

Completed Groups

Erin Longbrake, MD, PhD
Assistant Professor of Neurology
Robert Naismith, MD
Professor of Neurology
Carrie Hersh, DO, MSc, FAAN
Multiple Sclerosis Specialist, Assistant Professor of Neurology
Eric Klawiter, MD, MSc
Associate Professor of Neurology
Erin Longbrake, MD, PhD
Assistant Professor of Neurology